在罕见疾病临床试验中增加多样性,公平性,包容性和可访问性
Gareth Baynam1, Simeón Baker2,3,4, Charles Steward2,3
1Rare Care Centre, Perth Children's Hospital, Perth, WA, Australia.
Pharmaceutical medicine
|July 8, 2024
概括
将多样性,公平,包容性和可访问性 (DEIA) 纳入罕见病临床研究是成功的关键. 积极的DEIA策略,专注于遗传多样性,提高试验通用性,使所有人群受益.
科学领域:
- 临床研究 临床研究
- 罕见疾病 罕见疾病
- 健康 公平 卫生 公平
背景情况:
- 多样性,公平,包容性和可访问性 (DEIA) 是医学研究的基础.
- 在罕见疾病研究中,参与者数量有限,这使得纳入对于试验成功和结果通用性至关重要.
- 现有的关于罕见疾病的DEIA文献正在增长,越来越多地关注遗传多样性.
研究的目的:
- 审查并提供关于主动将DEIA纳入罕见病临床研究的见解.
- 突出遗传多样性的重要性,在罕见疾病的DEIA框架内.
- 确定成功的案例研究和战略,以加强罕见病研究中的DEIA.
主要方法:
- 医学和灰色文献的全面审查.
- 分析了展示DEIA集成的案例示例.
- 专注于将遗传多样性纳入战略.
主要成果:
- 在罕见疾病研究中,DEIA原则越来越多地被采用.
- 患者倡导团体,专业协会和资助者正在制定有意的DEIA策略和指标.
- 已经有成功的例子来吸引服务不足和代表性不足的人群.
结论:
- 积极的DEIA整合对于罕见疾病临床研究的成功至关重要.
- 遗传多样性是DEIA在这个领域的一个关键组成部分.
- 利用成功的案例研究可以指导未来的DEIA倡议,最终通过多样化的数据洞察力造福所有人群.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Hazard Ratio
110
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
110
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125


